Rambhia Kunal J, Watson Matthew, Sell Tara Kirk, Waldhorn Richard, Toner Eric
Center for Biosecurity of the University of Pittsburgh Medical Center, 621 East Pratt Street, Baltimore, MD 21202, USA.
Biosecur Bioterror. 2010 Dec;8(4):321-30. doi: 10.1089/bsp.2010.0043. Epub 2010 Nov 2.
The 2009 H1N1 pandemic stimulated a nationwide response that included a mass vaccination effort coordinated at the federal, state, and local levels. This article examines a sampling of state and local efforts during the pandemic in order to better prepare for future public health emergencies involving mass distribution, dispensing, and administration of medical countermeasures. In this analysis, the authors interviewed national, state, and local leaders to gain a better understanding of the accomplishments and challenges of H1N1 vaccination programs during the 2009-10 influenza season. State and local health departments distributed and administered H1N1 vaccine using a combination of public and private efforts. Challenges encountered during the vaccination campaign included the supply of and demand for vaccine, prioritization strategies, and local logistics. To improve the response capabilities to deal with infectious disease emergencies, the authors recommend investing in technologies that will assure a more timely availability of the needed quantities of vaccine, developing local public health capacity and relationships with healthcare providers, and enhancing federal support of state and local activities. The authors support in principle the CDC recommendation to vaccinate annually all Americans over 6 months of age against seasonal influenza to establish a standard of practice on which to expand the ability to vaccinate during a pandemic. However, expanding seasonal influenza vaccination efforts will be an expensive and long-term investment that will need to be weighed against anticipated benefits and other public health needs. Such investments in public health infrastructure could be important for building capacity and practice for distributing, dispensing, and administering countermeasures in response to a future pandemic or biological weapons attack.
2009年甲型H1N1流感大流行引发了全国性的应对行动,其中包括在联邦、州和地方各级协调开展的大规模疫苗接种工作。本文审视了大流行期间一些州和地方的应对举措,以便为未来涉及医疗应对措施大规模分发、配发和接种的突发公共卫生事件做好更充分准备。在这项分析中,作者采访了国家、州和地方的领导人,以更好地了解2009 - 10流感季甲型H1N1流感疫苗接种计划的成就与挑战。州和地方卫生部门通过公共和私人合作的方式分发和接种甲型H1N1流感疫苗。疫苗接种活动中遇到的挑战包括疫苗供应与需求、优先排序策略以及地方物流。为提高应对传染病突发事件的能力,作者建议投资相关技术,以确保更及时地提供所需数量的疫苗,发展地方公共卫生能力以及与医疗服务提供者的关系,并加强联邦政府对州和地方活动的支持。作者原则上支持美国疾病控制与预防中心(CDC)的建议,即每年为所有6个月以上的美国人接种季节性流感疫苗,以此确立一种操作标准,以便在大流行期间扩大疫苗接种能力。然而,扩大季节性流感疫苗接种工作将是一项昂贵的长期投资,需要权衡预期效益和其他公共卫生需求。对公共卫生基础设施的此类投资对于建设应对未来大流行或生物武器袭击时分发、配发和接种应对措施的能力及实践可能至关重要。